Karolinska University Hospital

• Studies to gain insight how the drugs PCSK9-inhibitors and statins affect cholesterol and bile acid metabolism Pending
  2023-505726-34-02 Phase IV 1 country
• HEMO trial - A randomized controlled trial of heparin bolus mobilization prior to peripheral hematopoietic cell collection from patients wit… Pending
  2023-509534-18-01 Phase II 1 country HEPARIN SODIUM; SODIUM CHLORIDE
• A multicentre, prospective, open-label study with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predi… Pending
  2024-512721-89-00 Phase II 1 country GALLIUM (68GA) TEZATABEP MATRAXETAN; TRASTUZUMAB DERUXTECAN
• Cell-based immunotherapy in solid organ transplantation to minimize systemic immunosuppression Pending
  2024-514866-37-01 1 country DSIMC
• K-SAB trial Pending
  2024-515250-25-00 Phase I (Other) 1 country
• Mesenchymal stromal cell therapy for rehabilitation after hip fracture. Pending
  2024-517010-15-01 Phase I (Other) 1 country
• Early mental response to hormonal treatment in transgender men - The EMRE Study Pending
  2024-517052-35-00 Phase IV 1 country
• ProFertil Pending
  2024-518977-32-00 Phase III 1 country TRIPTORELIN
• A study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccina… Pending
  2024-519060-40-00 Phase I (Other) 1 country
• Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone ther… Pending
  2024-520435-33-00 Phase III 1 country ESTRADIOL; NORETHISTERONE ACETATE, ESTRADIOL; PROGESTERONE, MICRONISED
• NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour … Pending
  2025-521006-18-00 Phase II 1 country NIVOLUMAB
• The REFINE study Pending
  2025-522133-66-00 Phase III 1 country
• Waiting on Atrial fibrillation Intervention Therapy (WAIT) Study Pending
  2025-524182-25-00 Phase IV 1 country SEMAGLUTIDE
• Montelukast as disease modifying treatment in mild-moderate Parkinson’s disease, an open-label, phase II extension trial (MONTPARK_OLE) Pending
  2026-525906-37-00 Phase III 1 country
• REPO-HYPER II Recruiting
  2024-520231-33-00 Phase II 1 country FOLIC ACID; TADALAFIL; VERICIGUAT
• Levosimendan in Cardiac Arrest: A Randomized Double-blinded Clinical Phase II Trial (LeICA) Recruiting
  2024-517279-20-02 Phase II 1 country LEVOSIMENDAN
• The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients wi… Recruiting
  2024-514879-17-00 Phase III 4 countries
• Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone… Recruiting
  2024-513416-98-00 Phase II 2 countries EMPAGLIFLOZIN; PIOGLITAZONE; SEMAGLUTIDE
• NEoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The… Recruiting
  2022-500966-82-00 Phase III 4 countries CARBOPLATIN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PACLITAXEL
• Sodium selenite in patients with advanced carcinoma: SECAR 1c Recruiting
  2025-522798-13-00 Phase I/II 1 country SODIUM SELENITE PENTAHYDRATE
• IMAGINE 1 Recruiting
  2025-522290-11-00 Phase I (Other) 1 country
• Prostate Androgen Response Investigation using a Stratification BIOmarker - PARIS-BIO Recruiting
  2025-520639-17-00 Phase II 1 country DAROLUTAMIDE
• SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melano… Recruiting
  2024-519593-39-00 Phase III 1 country IPILIMUMAB; NIVOLUMAB
• RECURrence of Atrial Fibrillation after cardioversion of patients randomized to open-label treatment with dapagliflozin or usual care (RECUR… Recruiting
  2024-513719-28-00 Phase III/IV 1 country

Showing 1–24 of 58 trials